News stories about Agilent Technologies (NYSE:A) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Agilent Technologies earned a daily sentiment score of 0.12 on Accern’s scale. Accern also gave news headlines about the medical research company an impact score of 46.3042641478145 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:
- UC Davis Microscope That Uses Ultraviolent Instead of Visible Light Emerging as Powerful Diagnostic Tool (prweb.com)
- Top-notch Stocks to Watch: Trinity Industries, Inc. (TRN), Agilent Technologies, Inc. (A) – Market Movers (financialqz.com)
- Agilent Technologies, Inc. breached its 50 day moving average in a Bearish Manner : A-US : December 5, 2017 (finance.yahoo.com)
- Thrashing Stocks: Anadarko Petroleum Corporation, (NYSE: APC), Agilent Technologies, Inc., (NYSE: A), Fibria … – Stocks In The News (press release) (tradingnewsnow.com)
- Dodge Agilent’s Bubble Price – Seeking Alpha (seekingalpha.com)
A has been the subject of a number of recent research reports. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price objective for the company in a research note on Tuesday, October 31st. Robert W. Baird restated a “buy” rating and issued a $70.00 price objective on shares of Agilent Technologies in a research note on Friday, October 20th. Cowen restated a “hold” rating and issued a $65.00 price objective on shares of Agilent Technologies in a research note on Thursday, September 28th. Jefferies Group restated a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research note on Wednesday, August 9th. Finally, BidaskClub cut shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 12th. Six research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $68.34.
Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.05. The business had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.96%. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter last year, the company posted $0.59 EPS. equities analysts predict that Agilent Technologies will post 2.58 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be given a dividend of $0.149 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.91%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio (DPR) is 25.24%.
In other Agilent Technologies news, insider Patrick Kaltenbach sold 5,000 shares of the stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.26, for a total transaction of $326,300.00. Following the sale, the insider now owns 45,143 shares of the company’s stock, valued at approximately $2,946,032.18. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Michael R. Mcmullen sold 16,492 shares of the stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $65.33, for a total transaction of $1,077,422.36. Following the sale, the chief executive officer now directly owns 211,872 shares in the company, valued at approximately $13,841,597.76. The disclosure for this sale can be found here. Insiders have sold a total of 151,114 shares of company stock valued at $10,359,388 in the last quarter.
ILLEGAL ACTIVITY WARNING: “Agilent Technologies (A) Receiving Somewhat Favorable Media Coverage, Study Shows” was published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.com-unik.info/2017/12/05/agilent-technologies-a-receiving-somewhat-favorable-media-coverage-study-shows.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
What are top analysts saying about Agilent Technologies Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Agilent Technologies Inc. and related companies.